Biden reinstates limits on US military landmine use


Anti-personnel landmines present both an immediate explosive threat, causing many civilian casualties around the world each year, but also have long-term effects on mental health, access to clean water and medical care, and more.

The New York Times: Biden bans use of most anti-personnel landmines, reversing Trump-era policy

The United States on Tuesday restricted the use of landmines by its military around the world except on the Korean Peninsula, honoring President Biden’s campaign pledge to reverse a Trump-era policy he had described as “reckless”. The move effectively reverts to a 2014 policy established by the Obama administration that banned the use of antipersonnel landmines except for the defense of South Korea. The Trump administration eased those restrictions in 2020, citing a new emphasis on strategic competition with major powers with large militaries. (Crowley and Ismay, 6/21)

In monkeypox updates —

AP: UK to offer monkeypox vaccines to some gay and bisexual men

British health officials will start offering vaccines to some men who have sex with men who are at highest risk of catching monkeypox, in a bid to curb the disease’s biggest outbreak in the world. beyond Africa. Doctors may consider vaccination for some men most at risk of exposure, Britain’s health security agency said in a statement on Tuesday. The agency identified those most at risk as men who have sex with men and have multiple partners, participate in group sex, or frequent venues where sex takes place onsite. (21/06)

The Atlantic: Squirrels could make monkeypox an eternal problem

In the summer of 2003, just weeks after an outbreak of monkeypox sickened about 70 people in the Midwest, Mark Slifka visited “the superspreader,” he told me. , “which infected half of Wisconsin’s cases”. Chewy, a prairie dog, had by then succumbed to the disease, which he had almost certainly caught in an exotic animal facility he had shared with infected rats from Ghana. But his owners’ other prairie dog, Monkey – named after the way he climbed into his cage – had contracted the pathogen and survived. “I was a little worried,” said Slifka, an immunologist at Oregon Health & Science University. All of the traits that made Monkey a charismatic pet also made him a contagious threat. He cuddled and nibbled his masters; when they left the house, he swaddled himself in their clothes until they returned. “That was cute,” Slifka told me. “But I was like, ‘Can Monkey be in his cage when we come?'” (Wu, 6/21)

In global covid vaccine developments —

Reuters: COVID-19 vaccination program for world’s poorest pushes for slower deliveries

Leaders of the global program to get COVID-19 vaccines to the world’s poorest are pushing makers such as Pfizer (PFE.N) and Moderna (MRNA.O) to cut or slow shipments of about half a billion of doses so that the doses are not wasted. COVAX, the program led by the World Health Organization, wants between 400 million and 600 million fewer doses of vaccine than those initially contracted from six pharmaceutical companies, according to internal documents seen by Reuters. (Rigby and Guarascio, 6/22)

Bloomberg: Moderna to build UK mRNA manufacturing and research center

Moderna Inc. plans to build a research and manufacturing center in the UK as part of a partnership with the government to provide the country with messenger RNA vaccines against future health threats. The deal will ensure National Health Service patients have access to mRNA vaccines targeting a range of diseases, including potential shots that can protect against several variants of Covid, the government said in a statement. The UK, which expects the first mRNA vaccine to be produced in 2025, declined to disclose the size of the investment or the location of the centre. (Hernanz Lizarraga, 6/21)

This is part of the KHN Morning Briefing, a summary of health policy coverage by major news outlets. Sign up for an email subscription.


Comments are closed.